1. Home
  2. ASMB vs CLDT Comparison

ASMB vs CLDT Comparison

Compare ASMB & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$29.44

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Logo Chatham Lodging Trust (REIT) of Beneficial Interest

CLDT

Chatham Lodging Trust (REIT) of Beneficial Interest

HOLD

Current Price

$8.67

Market Cap

362.9M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
CLDT
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
440.0M
362.9M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
CLDT
Price
$29.44
$8.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$44.20
$9.50
AVG Volume (30 Days)
70.0K
202.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
4.18%
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.29
Revenue Next Year
$235.63
N/A
P/E Ratio
N/A
$610.21
Revenue Growth
N/A
N/A
52 Week Low
$9.68
$6.08
52 Week High
$39.71
$8.71

Technical Indicators

Market Signals
Indicator
ASMB
CLDT
Relative Strength Index (RSI) 53.25 72.32
Support Level $29.31 $6.84
Resistance Level $30.54 N/A
Average True Range (ATR) 1.44 0.20
MACD 0.10 0.08
Stochastic Oscillator 68.18 94.13

Price Performance

Historical Comparison
ASMB
CLDT

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: